J. Kern

发表

Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans

I. König, J. Erdmann, W. Lieb, 2019, Front. Immunol..

Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression.

S. Lassmann, Claus-Werner Franzke, L. Bruckner-Tuderman, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa.

C. Has, J. Kohlhase, L. Bruckner-Tuderman, 2006, The Journal of investigative dermatology.

Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression

M. Idzko, M. Boerries, H. Busch, 2017, Oncotarget.

Phased‐array of microcoils allows MR microscopy of ex vivo human skin samples at 9.4 T

J. Hennig, J. Korvink, O. Gruschke, 2015, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Intraoral Human Herpes Viruses Detectable by PCR in Majority of Patients.

G. Varigos, Jaeyoung Kim, T. Yap, 2020, Oral diseases.

Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study

G. Varigos, C. Dolianitis, J. Kern, 2020, The Australasian journal of dermatology.

Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII.

L. Bruckner-Tuderman, C. Sitaru, J. Kern, 2008, The Journal of investigative dermatology.

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)

H. Cleland, C. Katelaris, J. Trubiano, 2022, BMJ Open.

Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.

D. von Bubnoff, G. Häcker, N. von Bubnoff, 2017, The Journal of investigative dermatology.

Update on diagnosis and therapy of inherited epidermolysis bullosa

C. Has, J. Kern, 2008 .

The association of mycophenolate mofetil and human herpes virus infection

G. Varigos, T. Yap, J. Kern, 2020, The Journal of dermatological treatment.

Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy

F. Meiss, J. Kern, A. May, 2019, Journal of cutaneous pathology.

Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis

R. Eming, M. Goebeler, T. Hashimoto, 2017, The British journal of dermatology.

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

D. Zillikens, H. Orzechowski, R. Eming, 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Signiﬁcant Prognostic Value for Progression-Free Survival

G. Häcker, D. Bubnoff, F. Meiss, 2018 .

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa.

C. Gretzmeier, Mei Chen, D. Woodley, 2021, The Journal of investigative dermatology.

Overexpression of the Flii gene increases dermal–epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita

D. Zillikens, D. Murrell, R. Arkell, 2011, The Journal of pathology.

Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa

C. Has, J. Kohlhase, L. Bruckner-Tuderman, 2011, Journal of Medical Genetics.

Collagen XVII.

C. Has, J. Kern, 2010, Dermatologic clinics.

S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid

D. Zillikens, H. Orzechowski, R. Eming, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Annular Flaccid Pustules on the Trunk.

D. Kiritsi, J. Kern, M. Hoch, 2017, JAMA dermatology.

Diagnostics of autoimmune bullous diseases in German dermatology departments

H. Gollnick, J. Ring, C. Bayerl, 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

L. Misery, A. Dupuy, O. Dereure, 2019, The Journal of investigative dermatology.

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study

D. Murrell, V. Werth, R. Sinclair, 2021, The British journal of dermatology.

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid

D. Zillikens, H. Orzechowski, R. Eming, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus

M. Richard, D. Murrell, V. Werth, 2016, The British journal of dermatology.

Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease

T. Yap, J. Kern, Yonatan Kok, 2021, The Australasian journal of dermatology.

One goal, different strategies – molecular and cellular approaches for the treatment of inherited skin fragility disorders

M. Röcken, R. Handgretinger, L. Bruckner-Tuderman, 2013, Experimental dermatology.

Systemic retinoids for treatment of recalcitrant IgA pemphigus

F. Schauer, D. Kiritsi, J. Kern, 2018, Orphanet Journal of Rare Diseases.

Cutaneous Pathology of the Head and Neck

Benjamin C. Wood, T. Yap, J. Kern, 2018 .

Overlap of IgA pemphigus and linear IgA dermatosis in a patient with ulcerative colitis: a mere coincidence?

W. Kreisel, M. Hertl, L. Bruckner-Tuderman, 2014, Acta dermato-venereologica.

Esophageal lichen planus: towards diagnosis of an underdiagnosed disease

C. Monasterio, A. Schmitt-Graeff, F. Schauer, 2019, Scandinavian journal of gastroenterology.

Chronic colitis due to an epithelial barrier defect: the role of kindlin‐1 isoforms

E. Haan, C. Herz, O. Opitz, 2007, The Journal of pathology.

Esophageal involvement is frequent in lichen planus: study in 32 patients with suggestion of clinicopathologic diagnostic criteria and therapeutic implications

W. Kreisel, J. Kuhlmann, P. Deibert, 2016, European journal of gastroenterology & hepatology.

Bullous pemphigoid in infants: characteristics, diagnosis and treatment

F. Schauer, H. Ott, E. Schmidt, 2014, Orphanet Journal of Rare Diseases.

Recalcitrant Pemphigus Vulgaris Responding to Systemic Tacrolimus

L. Bruckner-Tuderman, J. Kern, S. Hofmann, 2010, Dermatology.

Late‐onset malalignment of the great toenails

J. Kern, A. Howard, C. Wang, 2019, The Australasian journal of dermatology.

De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris – a systematic review

T. Yap, J. Kern, J. Mcclatchy, 2021, Expert opinion on biological therapy.

The use of cassettes for the collection of nail biopsy specimens

J. Kern, B. Doolan, Chin-Guan Tan, 2019, The Australasian journal of dermatology.

Rat Model for Dominant Dystrophic Epidermolysis Bullosa: Glycine Substitution Reduces Collagen VII Stability and Shows Gene-Dosage Effect

M. Bader, L. Bruckner-Tuderman, C. Özcelik, 2013, PloS one.

Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

O. Paul, P. Ruther, T. Magin, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

T. Bley, R. Fässler, M. Erlacher, 2008, The Journal of clinical investigation.

Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.

C. Bodemer, E. Sprecher, D. Murrell, 2022, The British journal of dermatology.

Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

C. Davis, J. Kern, A. Schwieger-Briel, 2019, Trials.

Acromelanosis Albo-Punctata: A Distinct Inherited Dermatosis with Acral Spotty Dyspigmentation without Systemic Involvement

P. Itin, R. Happle, C. Has, 2012, Dermatology.

TGM5 mutations impact epidermal differentiation in acral peeling skin syndrome.

C. Has, L. Bruckner-Tuderman, Cristina Cobzaru, 2012, The Journal of investigative dermatology.

Alitretinoin in the treatment of palmoplantar mycosis fungoides: a new and promising therapeutic approach

F. Meiss, J. Kern, K. Technau-Hafsi, 2015, Clinical and experimental dermatology.

A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five‐year period

J. Kern, J. Hunt, R. Dunn, 2021, The Australasian journal of dermatology.

Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.

O. Schilling, C. Gretzmeier, M. Biniossek, 2017, Matrix biology : journal of the International Society for Matrix Biology.

Global remodelling of cellular microenvironment due to loss of collagen VII

H. Busch, O. Schilling, J. Dengjel, 2013, Molecular systems biology.

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

W. Römer, L. Bruckner-Tuderman, J. Madl, 2016, Cancer research.

Bluish grey pigmentation

J. Kern, A. Arnold, E. Anthony, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

J. Dengjel, Kerstin Thriene, L. Bruckner-Tuderman, 2015, EMBO molecular medicine.

Disruption of ERBB2IP is not associated with dystrophic epidermolysis bullosa in both father and son carrying a balanced 5;13 translocation.

K. Kutsche, C. Has, L. Bruckner-Tuderman, 2005, The Journal of investigative dermatology.

Blue–black discolouration of the proximal lunula of the thumbnail

John C. Su, J. Kern, Chin-Guan Tan, 2019, The Australasian journal of dermatology.

Collagen VII plays a dual role in wound healing.

L. Bruckner-Tuderman, A. Nyström, J. Kern, 2013, The Journal of clinical investigation.

Clinical and histopathological features of onychopapilloma in an Australian setting: A case series of 50 patients

J. Kern, A. Howard, Saurabh Prakash, 2022, The Australasian journal of dermatology.

Vegetating plaques in a patient with a seizure disorder

T. Bast, J. Kern, A. Schwieger-Briel, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

C‐terminally truncated kindlin‐1 leads to abnormal adhesion and migration of keratinocytes

C. Herz, S. Ussar, C. Has, 2008, The British journal of dermatology.

Forty‐two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort

C. Has, S. Emmert, L. Bruckner-Tuderman, 2009, The British journal of dermatology.

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)

D. Murrell, John C. Su, J. Kern, 2021, JAAD international.

Basics of immunohistochemistry.

V. Schacht, Vivien Schacht, Johannes S Kern, 2015, The Journal of investigative dermatology.

Australian Teledermatology experience during COVID‐19

J. Kern, V. Morgan, L. Scardamaglia, 2021, The Australasian journal of dermatology.

BG01: Safety and efficacy of oleogel‐S10 (birch triterpenes) for epidermolysis bullosa: results of a 12‐month interim analysis of the open‐label phase from the EASE study

D. Murrell, M. O’Sullivan, J. Kern, 2022, British Journal of Dermatology.

Clinical and dermoscopic features of nail unit melanoma in an Australian nail clinic cohort.

J. Kern, A. Howard, A. Arasu, 2023, Australasian Journal of Dermatology.

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

H. Shimizu, F. Schauer, L. Bruckner-Tuderman, 2018, The British journal of dermatology.

Mouse models for dominant dystrophic epidermolysis bullosa (DDEB) carrying common human point mutations recapitulate the human disease.

K. Pang, Blake R. C. Smith, G. Varigos, 2021, Disease models & mechanisms.

Successful management of treatment resistant nail psoriasis with tildrakizumab

J. Kern, A. Howard, Z. Low, 2021, The Australasian journal of dermatology.

CSL324, a G-CSF receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.

M. Ng, G. Varigos, J. Field, 2023, The British journal of dermatology.

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts

C. Bodemer, J. Uitto, E. Sprecher, 2020, Journal of the American Academy of Dermatology.

Conditional collagen VII inactivation allows analysis of anchoring fibril stability and function in vivo and reveals a major role of fibroblasts in collagen VII expression

R. Fässler, L. Bruckner-Tuderman, J. Kern, 2009 .

Insect bite‐like reaction in a patient with chronic lymphocytic leukemia

F. Meiss, J. Kern, Carina M Butzmann, 2014, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Recurrent ulceronecrotic plaques and nodules with spontaneous remission

F. Meiss, M. Wolter, J. Kern, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Pathergy: a review of potential mechanisms and novel therapeutic targets

J. Frew, J. Kern, A. Honigman, 2022, Wound Practice and Research.

A simple solution for habit‐tic nail deformity

M. Tam, J. Kern, Jacqueline Jiang, 2023, The Australasian journal of dermatology.

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris

P. Sugerman, D. Murrell, V. Werth, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Ultralow‐dose rituximab in pemphigus: a single‐centre experience

T. Yap, J. Kern, L. Scardamaglia, 2021, The British journal of dermatology.

Autoreactivity to BP180 Neoepitopes in Patients With Pemphigoid Gestationis.

F. Schauer, K. Izumi, D. Kiritsi, 2022, JAMA dermatology.

One goal, different strategies – molecular and cellular approaches for the treatment of inherited skin fragility disorders

M. Röcken, R. Handgretinger, L. Bruckner-Tuderman, 2013, Experimental dermatology.

Cell- and protein-based therapy approaches for epidermolysis bullosa.

L. Bruckner-Tuderman, A. Nyström, J. Kern, 2013, Methods in molecular biology.